![Kathleen Glaub](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kathleen Glaub
Gründer bei
CuraSen Therapeutics, Inc.
Vermögen: - $ am 30.06.2026
Profil
Kathleen Sereda Glaub is the founder of CuraSen Therapeutics, Inc., founded in 2016, serving as Chief Executive Officer & Director since 2016.
Current job includes Director at IO Biotech ApS since 2018.
Former jobs include Chief Executive Officer & Director at Afferent Pharmaceuticals, Inc. from 2014 to 2016; Independent Director at Codexis, Inc. from 2014 to 2019; Independent Director at Aligos Therapeutics, Inc.; Independent Director at Escient Pharmaceuticals, Inc.; Independent Director at IO Biotech, Inc. from 2018 to 2026; Chief Financial Officer & Senior Vice President at Cell Genesys, Inc.; Treasurer at Genentech, Inc.; Principal at Intel Corp.; and President at Plexxikon, Inc. from 2001 to 2013.
Education includes undergraduate degree from the University of California, Berkeley and MBAistration from Kellogg School of Management.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
IO BIOTECH, INC. -.--% | 05.06.2025 | 0 ( -.--% ) | - $ | 30.06.2026 |
Aktive Positionen von Kathleen Glaub
| Unternehmen | Position | Beginn |
|---|---|---|
IO Biotech ApS
 IO Biotech ApS BiotechnologyHealth Technology Develops disruptive immune therapies | Direktor/Vorstandsmitglied | 11.06.2018 |
CuraSen Therapeutics, Inc.
 CuraSen Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops novel treatments for psychiatric and neurodegenerative diseases | Gründer | 18.04.2016 |
Ehemalige bekannte Positionen von Kathleen Glaub
| Unternehmen | Position | Ende |
|---|---|---|
| IO BIOTECH, INC. | Direktor/Vorstandsmitglied | 31.03.2026 |
| CODEXIS, INC. | Direktor/Vorstandsmitglied | 30.09.2019 |
Afferent Pharmaceuticals, Inc.
 Afferent Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops novel, selective drugs for the treatment of a range of debilitating neurogenic disorders | Vorstandsvorsitzender | 01.07.2016 |
Plexxikon, Inc.
 Plexxikon, Inc. Miscellaneous Commercial ServicesCommercial Services Provides clinical and medical drug discovery and development services | Präsident | 01.05.2013 |
| ALIGOS THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | - |
Ausbildung von Kathleen Glaub
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
53
Beziehungen ersten Grades
13
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 13 |
|---|---|
Cell Genesys, Inc.
 Cell Genesys, Inc. Pharmaceuticals: MajorHealth Technology Develops human disease therapies based on innovative gene modification technologies | Health Technology |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Intel Corp.
 Intel Corp. SemiconductorsElectronic Technology Engages in design, development, manufacture and sale of CPUs and integrated circuits to computing and related end products | Electronic Technology |
Plexxikon, Inc.
Plexxikon, Inc. Miscellaneous Commercial ServicesCommercial Services Provides clinical and medical drug discovery and development services | Commercial Services |
Codexis, Inc.
 Codexis, Inc. Chemicals: SpecialtyProcess Industries Develops biocatalytic chemical processes | Process Industries |
Afferent Pharmaceuticals, Inc.
Afferent Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops novel, selective drugs for the treatment of a range of debilitating neurogenic disorders | Health Technology |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kellogg School of Management
 Kellogg School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
IO Biotech ApS
IO Biotech ApS BiotechnologyHealth Technology Develops disruptive immune therapies | Health Technology |
CuraSen Therapeutics, Inc.
CuraSen Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops novel treatments for psychiatric and neurodegenerative diseases | Health Technology |
Escient Pharmaceuticals, Inc.
 Escient Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a drug discovery and development company | Health Technology |
Aligos Therapeutics, Inc.
 Aligos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops targeted, curative therapies for hepatologic diseases and viral infections | Health Technology |
IO Biotech, Inc.
 IO Biotech, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops novel, immune-modulating cancer therapies | Health Technology |
